Ping An Good Doctor Partners with China Biotech Services for Cancer Testing and BNCT Treatment
China-based Ping An Healthcare and Technology Co., Ltd (HKG: 1833), also known as PingAn Good...
Kelun Pharma’s SKB264 ADC Receives NMPA Green Light for Phase II Solid Tumor Study
China-based Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422) announced that its antibody drug conjugate (ADC)...
Luye Pharma Initiates Phase III Study of Trulicity Biosimilar BA5101 in China
China-based Luye Pharma Group (HKG: 2186) announced the initiation of a Phase III clinical study...
Shanghai Electric and Siemens Partner on Localization of High-End Medical Equipment
China’s Shanghai Electric Group has partnered with Germany-based Siemens Healthineers to localize high-end medical equipment,...
Beijing Science Sun’s LZ901 Shingles Vaccine Receives FDA IND Approval
China-based Beijing Science Sun Pharmaceutical Co., Ltd (SHE: 300485) announced that its subsidiary Beijing Luzhu...
Ningbo HicRen Biotech Completes RMB100M Pre-Series C Financing for Orthopedic Robots
Ningbo HicRen Biotechnology Co., Ltd, a China-based robotics-driven minimally invasive orthopedics platform, announced the completion...
CStone Pharmaceuticals Explores Strategic Options Including Buyout
China-based CStone Pharmaceuticals (HKG: 2616) is evaluating strategic options, including a potential buyout, according to...
BeiGene’s Tislelizumab Faces FDA Delay Due to Inspection Hurdles
BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) announced a delay in the U.S. FDA’s decision...
Frontier Biotech and Asymchem Partner on COVID-19 Drug FB2001 Development
China-based Frontier Biotechnologies Inc. (SHE: 200342) announced a strategic partnership with Asymchem Laboratories (Tianjin) Co.,...
Acotec Scientific’s AcoArt Orchid & Dhalia DCB Wins China Approval for AVF PTA
China-based Acotec Scientific Holdings Ltd (HKG: 6669) announced that its AcoArt Orchid & Dhalia DCB,...
Orion Holdings to Build Jining Vaccine Plant in China’s Shandong Province
South Korea-based conglomerate Orion Holdings Corp. will enter China’s vaccine market by constructing a manufacturing...
Hangzhou DAC Biotech Doses First Patient in DXC007 AML Study
China-based Hangzhou DAC Biotech Co., Ltd announced the first patient enrollment and dosing in a...
Shanghai Ark Bio Raises Series D Funding to Advance Pediatric and Respiratory Drug Pipeline
China-based Shanghai Ark Biopharmaceutical Co., Ltd has completed a Series D financing round, following its...
Simcere’s Trilaciclib Wins NMPA Approval for Chemotherapy Myeloprotection
Jiangsu Simcere Pharmaceutical Co., Ltd’s trilaciclib has received marketing approval from the National Medical Products...
China’s 2021 Healthcare Report Shows Rising Life Expectancy, Increased Medical Spending
China’s National Health Commission (NHC) released the “Healthcare Statistical Communique 2021,” revealing increased healthcare spending,...
Sinopharm Biotec and Ganzhou Government Partner on Medical Testing and Biotech R&D
Sinopharm China National Biotec Group Co., Ltd (CNBG) announced a strategic partnership with the government...
Basecare Medical and Haier Biomedical Partner on IVF Cryopreservation Tech
China-based IVF specialist Suzhou Basecare Medical Co., Ltd (HKG: 2170) announced a strategic partnership with...
Huadong Medicine’s Biosimilar Victoza (Liraglutide) Accepted for NMPA Review
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that its market filing for a biosimilar...
CorrectSequence Therapeutics’ tBE Tech Wins USPTO Patent for Gene Editing
Shanghai-based gene editing firm CorrectSequence Therapeutics announced it has received a patent from the United...
Zai Lab’s Efgartigimod NDA Accepted by NMPA for Myasthenia Gravis
Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) announced that the National Medical Products Administration (NMPA)...